TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy.
Ting ShenShan-Feng LiJia-Lin WangTing ZhangSong ZhangHai-Tao ChenQian-Yi XiaoWei-Hua RenChao LiuBo PengXiao-Na JiYang YangPei-Xin LuTao-Yang ChenLong YuYuan JiDe-Ke JiangPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
TP53 R249S mutation in ctDNA may serve as a promising prognosis biomarker for HCC patients with or without hepatectomy.